Both in Pharmaceuticals
Crescent Biopharma vs Faeth Therapeutics
Over the past year CBIO returned −33.5% and FTH returned −48.6%; their daily moves had a correlation of 0.51.
CBIO −33.5% FTH −48.6%Growth of $1, one year, split-adjusted
| Metric | CBIO | FTH |
|---|---|---|
| Price | $12.91 | $19.23 |
| Market cap | $479.6M | $496.9M |
| Today | −4.23% | +2.89% |
| 1 month | −9.8% | −32.2% |
| 6 months | −28.0% | — |
| Year to date | +8.9% | — |
| 1 year | +3.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 40.4× | — |
| Net cash | $171.6M | $186.4M |
| Dividend yield | — | — |
| Volatility (60d) | 69.2% | — |
| Short % of float | 21.2% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).